We leveraged a large, well-characterized autopsy dataset with harmonized neuropathological and cognitive data, allowing for precise stratification of neuritic plaque-negative, neurofibrillary tau-positive individuals—a biologically distinct and underrepresented group in AD research. The gene discussed is MAPT; the disease is Alzheimer disease.